Antipsychotic medication in schizophrenia: a review

J Lally, JH MacCabe - British medical bulletin, 2015 - academic.oup.com
Introduction Antipsychotic medications are mainstays in the treatment of schizophrenia and
a range of other psychotic disorders. Sources of data Recent meta-analyses of antipsychotic …

[HTML][HTML] Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: a systematic review

S García, M Martínez-Cengotitabengoa… - Journal of clinical …, 2016 - journals.lww.com
Antipsychotics are the drugs prescribed to treat psychotic disorders; however, patients often
fail to adhere to their treatment, and this has a severe negative effect on prognosis in these …

[图书][B] Deadly medicines and organised crime: how big pharma has corrupted healthcare

P Gotzsche - 2019 - taylorfrancis.com
PRESCRIPTION DRUGS ARE THE THIRD LEADING CAUSE OF DEATH AFTER HEART
DISEASE AND CANCER. In his latest ground-breaking book, Peter C Gotzsche exposes the …

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey… - The Lancet, 2013 - thelancet.com
Background The question of which antipsychotic drug should be preferred for the treatment
of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide …

Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis

MT Samara, M Dold, M Gianatsi… - JAMA …, 2016 - jamanetwork.com
Importance In treatment-resistant schizophrenia, clozapine is considered the standard
treatment. However, clozapine use has restrictions owing to its many adverse effects …

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of …

A Hasan, P Falkai, T Wobrock… - The World Journal of …, 2012 - Taylor & Francis
These updated guidelines are based on a first edition of the World Federation of Societies of
Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in …

International consensus study of antipsychotic dosing

DM Gardner, AL Murphy, H O'Donnell… - American Journal of …, 2010 - Am Psychiatric Assoc
Objective Potency equivalents for antipsychotic drugs are required to guide clinical dosing
and for designing and interpreting research studies. Available dosing guidelines are limited …

The NMDA receptor and schizophrenia: from pathophysiology to treatment

DT Balu - Advances in pharmacology, 2016 - Elsevier
Schizophrenia is a severe mental illness that affects almost 1% of the population worldwide.
Even though the etiology of schizophrenia is uncertain, it is believed to be a …

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

S Miyamoto, N Miyake, LF Jarskog… - Molecular …, 2012 - nature.com
Since the introduction of chlorpromazine and throughout the development of the new-
generation antipsychotic drugs (APDs) beginning with clozapine, the D 2 receptor has been …

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

S Leucht, C Corves, D Arbter, RR Engel, C Li, JM Davis - The Lancet, 2009 - thelancet.com
Background Because of the debate about whether second-generation antipsychotic drugs
are better than first-generation antipsychotic drugs, we did a meta-analysis of randomised …